Literature DB >> 20732919

Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease.

James D Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20732919     DOI： 10.1136/gut.2009.191015

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.

Authors:  Laura E Targownik; Samy Suissa
Journal:  Am J Gastroenterol       Date:  2015-09-01       Impact factor: 10.864

2.  Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases.

Authors:  Kevin Haynes; Timothy Beukelman; Jeffrey R Curtis; Craig Newcomb; Lisa J Herrinton; David J Graham; Daniel H Solomon; Marie R Griffin; Lang Chen; Liyan Liu; Kenneth G Saag; James D Lewis
Journal:  Arthritis Rheum       Date:  2013-01

3.  Association between anti-TNF-α therapy and all-cause mortality.

Authors:  Lisa J Herrinton; Liyan Liu; Lang Chen; Leslie R Harrold; Marsha A Raebel; Jeffrey R Curtis; Marie R Griffin; Daniel H Solomon; Kenneth G Saag; James D Lewis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-10-15       Impact factor: 2.890
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.